Latest news
17th December 2024
News
Pemberton supports the refinancing of cancer care provider GenesisCare UK
GenesisCare UK is the UK’s leading independent specialist cancer care provider…
18th November 2024
Pemberton backs Inflexion’s acquisition of Finanzen.net Group
1st November 2024
Pemberton Supports Natra’s Acquisition of Gudrun
Research
Sign up here to receive our research articles to your inbox.
Send an email to marketing@pembertonam.com or click on the button below.
6th November 2024
Research
NAV Financing Offers Significant Benefits Beyond Dividend Recaps
As NAV Financing continues to gain traction across the private credit industry,…
24th July 2024
Sustainable Investing Report 2023/24
17th July 2024
Mid Year Review 2024
5th April 2024
Significant Risk Transfer (SRT) Chronicles 2024
28th February 2024
NAVigator Series: A Hypothetical Performance Analysis
21st February 2024
NAV Financing: Evolution within Fund Financing
7th February 2024
Building Resilient and Diversified Income Streams from Private Debt
31st January 2024
Outlook 2024
Case studies
27th January 2020
Quotient – Leading pharmaceutical and biotechnology company
28th June 2019
Travel Counsellors – UK-based travel business
6th December 2018